Eve Health Group Limited · ASX:EVE
Eve Health — Shareholder Meeting (November 2021)
26 slides from Eve Health's shareholder meeting presentation, Nov 25, 2021
Slide 1: November 2021
For personal use only Pic to go here November 2021
Slide 2: Our Core Values
For personal use only OUR CORE VALUES These are our ingrained principles that help guide our actions, decisions and serves as our cultural cornerstones. Embrace unique and creative Be transparent and committed to Strive to produce excellence Take ownership to care for the solutions to continuously d
Slide 3: Natural & High Quality Innovation
For personal use only NATURAL & HIGH QUALITY INNOVATION | 03
Slide 4: For personal use only
For personal use only To be a global and leading vertically integrated producer of high quality, innovative and sustainable health and wellness products that celebrate the natural goodness of Australian botanicals. Freehold and leased landholdings In-house and third party Alstonville facility and On
Slide 5: For personal use only
For personal use only Vertically integrated business model (Control of supply & manufacture). Capacity to respond to demand increases. Distribution base expanding internationally- Japan, North America and China. Collaboration with Probiotics Australia to expand probiotics range. Strong emphasis on m
Slide 6: For personal use only
For personal use only CtZ eve
Slide 7: Meluka Australia
For personal use only MELUKA AUSTRALIA Driven by a spirit of innovation to create retail products that help consumers stay healthy & rejuvenate their well-being. FY 19/20 FY 20/21 FY 21/22 | 07
Slide 8: Meluka Australia
For personal use only MELUKA AUSTRALIA RAW HONEY RANGE ESSENTIAL OILS RAW HONEY PROBIOTIC CONCENTRATE RANGE Meluka Australia premium certified Meluka Australia premium tea tree essential organic raw honeys that are oil and essential oil blends. Meluka Australia premium bio- traceable and sustainable
Slide 9: Key rationale
For personal use only Key rationale • Strong demand for existing product range. • Good consumer validation of health benefits. • High customer return rates. • Lower cost per customer acquisition rate. • Higher margin and overall return on investment. | 09
Slide 10: Unique probiotic strain
For personal use only UNIQUE PROBIOTIC STRAIN WITH Partnering with Australia’s first and only cGMP and TGA certified facility for probiotic API manufacturing, Probiotics Australia to develop an exclusive probiotic strain derived from Meluka Australia's beehives. Key therapeutic benefits of strain Ma
Slide 11: The Global Consumer & Digestive Health
The Global Consumer & Digestive Health For personal use only Belief Consumer Concerns Global consumers who Global consumers who Global consumers who identified a link exists between identified a link exists between acknowledge link between good good digestive health and good digestive health and dig
Slide 12: Consumer Demand & Return
Consumer Demand & Return Consumer Acquisition For personal use only & Return On Spend Consumer Search & Spend $ Cost Per Customer Acquisition Health consumers seek out probiotic solutions and spend more per annum vs raw honey. by Target Audience HONEY- LOYAL CUSTOMER 1 JAR / 2 MONTHS Annual spend Pr
Slide 13: Consumer segment: mild sufferer
TARGET AUDIENCE: ADULTS AGED 30 – 69 CONSUMER SEGMENT: MILD SUFFERER Probiotic Drinks only Range Meluka Pro-Culture Honey Blend® NEW Meluka Probiotic Immunity+ ™ Meluka Pro-Culture Honey Blend® USP + Fortification + Meluka Pro-Culture Honey Blend® useDrinks No Added Preservatives or Colours, No Adde
Slide 14: Consumer segments: advanced sufferer and wellness seeker
TARGET AUDIENCE: ADULTS AGED 30 – 69 CONSUMER SEGMENT: ADVANCED SUFFERER use only Range Meluka Pro-Culture Honey Blend® Meluka Pro-Culture Honey Blend® + Fortification USP + Fortification No Added Preservatives or Colours, No Added Preservatives or Colours, PREBIOTICS, PROBIOTICS & POSTBIOTIC SYSTEM
Slide 15: FY 21/22 product launch timeline
For personal use only FY 21/22 J U L A U G S E P O C T N O V D E C J A N - J U N Category: Honey • Vegan Honey Botanical Collection Raw Honey Luxe- Organic Cacao infused Raw Honey • Probiotic Honey Butter • Organic Ginger infused Raw Honey Probiotics Category: • Raw Honey Probiotic Concentrate with
Slide 16: For personal use only
For personal use only
Slide 17: Key Markets
Key Markets = \ og * = an XQ TAIWAN . { = J iS yi (Alva) AUSTRALIA eve XY. V2 HEALTH GROUP
Slide 18: Online distribution model for new markets
For personal use only ONLINE DISTRIBUTION MODEL FOR NEW MARKETS • One of the world’s largest online retailers is Amazon.com. The platform forms a key part of Meluka Australia’s online distribution model and acts as a gateway to enter our branded products into new markets (excluding Secure in-store L
Slide 19: FY2022 distributors and channels by market
FY2022 For personal use only USA AUSTRALIA JAPAN CANADA CHINA TAIWAN SINGAPORE Naturally Australian Products The Fair Traders Distribution (Nap), Inc. (49% Eve Owned) - Amazon (NSW) Bulk Oil Sales, Branded Meluka DISTRIBUTOR Amazon Yandi Biotech AIFYA International Group Amazon Australia Products Di
Slide 20: For personal use only
For personal use only
Slide 21: FY2021 revenue growth year on year
For personal use only FY2021 REVENUE GROWTH YEAR ON YEAR 3,000,000 +21% 2,500,000 2,000,000 1,500,000 +13% 1,000,000 +10% +50% 500,000 - Bulk sales Branded product sales Contract manufacturing Revenue 2020 2021 • All areas of business grew in FY2021 • Branded product sales up +200% when China is exc
Slide 22: FY2021 sales by category, region and channel
For personal use only FY2021 SALES BY CATEGORY SALES BY REGION SALES BY CHANNEL D I S T R I B U T O R C H I N A 10% H O N E Y & 3% P R O B I O T I C S 15% AUSTRALIA D I R E C T T O C O N S U M E R C O N T R A C T M A N U F A C T U R I N G 29% 5% 13% BULK OILS USA 72% 66% WHOLESALE 85% O T H E R ( J
Slide 23: Capital Structure
For personal use only November 2021 CAPITAL STRUCTURE ORDINARY SHARES 3,843,141,890 OPTIONS/RIGHTS 151,866,665 EVERHONEY MARKET CAP AUD $15M 17% EV AUD $13.7M KEY SHAREHOLDERS OTHER HONG KONG EVERHONEY 17% SHAREHOLDERS JUSHENG 50% 13% HONG KONG JUSHENG 13% DIRECTORS & MANAGEMENT 8% D I R E C T O R S
Slide 24: Outlook and growth priorities
For personal use only Expansion of distribution channels in Australia and USA Expansion of current product range in Japan and Singapore New product launches – additions to current ranges, plus introduction of new probiotic ranges. Focus on further product development and IP creation Growing demand f
Slide 25: Disclaimer
For personal use only This presentation has been prepared by EVE Investments Limited (“EVE”) to assist in informing interested parties about the Company and its progress. It should not be considered as an offer or invitation to subscribe for or purchase any securities in EVE or as an inducement to m
Slide 26: For personal use only
For personal use only ©E V E HEALTH GROUP 2021
Eve Health Group — Shareholder Meeting (November 2021) on 6ix